The KOSHINÉ Blog: Hair Wellness Starts Here
-
Is KX-826 Expensive? It Might Be Worth It.
When people first hear about KX-826, the common question is:“Isn’t this just another hair loss spray? Why is it more expensive than Minoxidil?” We get it.In the hair loss market, price and effectiveness often get mixed up — cheap doesn’t...
-
Worried About Side Effects from Hair Care Products? You’re Not Alone — Let’s Talk About It
When it comes to starting a scalp care routine, hesitation is completely normal. “Will it affect my body?”“Does it contain hormones?”“What if it makes my hair fall out more at first?” These are valid concerns — and you’re definitely not...
-
Sticky Roots and Drippy Sprays? Here’s Why KOSHINÉ Changed the Game.
You’ve probably been there. You finally decide to commit to a scalp care spray. You spray it on—and suddenly it’s dripping down your forehead, your scalp feels heavy, and your carefully styled hair?Ruined. Scalp care shouldn’t cost you your confidence—or...
-
Why Do You Keep Doubting Hair Loss Products? Because You Don’t Understand Them.
“This ingredient sounds so high-tech… is it really effective?”“Another ‘new drug’? Sounds like a marketing trap.”“They all look the same. Who should I trust?” We get it. Most people aren’t scientists. When you see something like “KX-826”, a totally unfamiliar...
-
Completion Of Patient Enrollment In Phase III Stage Of Pivotal Clinical Trial Of KX-826 Tincture 1.0% For The Treatment Of Male Adult AGA In China
Suzhou, 31 July, 2025-Kintor Pharmaceutical Limited (“Kintor Pharma”, HKEX: 9939), announced that the enrollment of 666 patients has been completed for the Phase III Stage of the Pivotal Clinical Trial of its in-house developed and potential first-in-class KX-826 tincture 1.0% for...
-
KOSHINÉ Anti-Hair Loss – Max Version: A DHT-Blocking Solution for Severe Hair Thinning
KOSHINÉ Anti-Hair Loss – Max Version A DHT-Blocking Care Solution for Severe Hair Thinning Why Choose the Max Version? When hair loss reaches a moderate to severe stage, regular shampoos and low-dose serums often fail to deliver results. The KOSHINÉ...